The F1 antigen of Yersinia pestis has been identified as one of the major protective antigens of this bacterium. The present study aims to delineate major and minor antigenic sites of F1 antigen. Using algorithmic predictions, five peptide sequences (P1, P2, P3, P4 and P5) spanning the C-terminal region were identified and synthesized. Antibodies were generated in mice against the peptides, native F1 protein and polymerized F1 antigen using liposomes as mode of immunization. Cross-reactivity between F1 antigen and peptides was tested using both solid and solution phase assays. Similar assays were done with rabbit anti-F1 sera. Competitive inhibition assays using a different combination of antisera and competing antigen identified P2 peptide FFVRSIGSKGGKLAAGKYTDAVTV (142^165) as the immunodominant sequence. The results indicate that this sequence appears to be exposed on the surface of F1 molecule. In a solid phase binding assay, P2 peptide was recognized even at high F1 antisera dilution. However, when antisera raised to different peptides were tested for binding to F1 antigen, antisera to P4 peptide showed maximal immunoreactivity. This implies more accessibility of this region during immobilization on solid surface. There was consistency in the results obtained for different strains of mice as well as for the rabbit antisera. Such a sequence of F1 antigen, which is recognized widely in animals of different genetic background, would be useful for diagnosis and subunit vaccine. ß
Introduction
Yersinia pestis is an etiologic agent of pneumonic and bubonic plague which is still active in various regions of the world [1] . In the last decade, the situation has worsened with the re-emergence of plague in areas where it was absent for several years like India, Madagascar and Mozambique [2] . Plague is a serious health threat as it severely disrupts the commerce and the public health systems.
The currently available vaccines for human use comprise heat-killed or formaldehyde-killed suspensions of Y. pestis cells or an attenuated live EV76 strain [3] . While the immunization with whole cell vaccine has shown some protection against bubonic plague, its ability to confer protection against pneumonic plague is questionable [4] . Moreover, immunity induced by such vaccines is shortlived and requires boosting at regular intervals to maintain antibody level [5] .
Clearly, there is a need for an improved plague vaccine that may overcome the limitations of presently available whole cell vaccine. An alternative approach will be utilization of protective epitopes from immunodominant antigen of Y. pestis. Y. pestis possesses a complex array of virulence factors that are encoded either chromosomally or plasmid [6] . Two well-characterized antigens are F1 and V antigen. There are reports to indicate that F1 and V proteins alone or in combined forms elicit systemic as well as local immunity in experimental animals [7] . It is interesting to note that with whole cell vaccine, the immune response was mostly directed against F1 antigen, thereby indicating its immunodominance. Moreover, use of V antigen as immunoprophylactic is limited due to its instability [8] . Hence in the present study, emphasis was laid on F1 antigen, an outer membrane capsular protein of Y. pestis, which is fully expressed at 37³C. This antigen has been shown to be an e¡ective protective immunogen in many animal species [9, 10] . In all these studies, a positive correlation was observed between high anti-F1 titers and clinical protection. Such observations have made F1 antigen an attractive candidate for the development of a subunit-based vaccine against plague and also for diagnostic purposes as well as sero surveillance studies.
Though a considerable amount of work has been carried out on the immunogenicity of native F1 antigen [9, 11] , the potential immunogenic centers responsible for inducing protective immune response are not studied. This would require the identi¢cation of protective epitopes as well as delivery of antigen through a modi¢ed form of immunization in order to maintain peak and sustainable antibody levels.
Liposomes have been envisaged as delivery vehicles for drug targeting as well as inducing antibody response to protein antigens [12] . Though alum has been considered as an acceptable adjuvant for humans, sometimes its applicability is limited due to adverse side e¡ects. Hence, an alternate approach of delivering the weak peptide antigens in biodegradable and biocompatible phospholipid complex was attempted.
Although the putative epitopes of F1 antigens have been reported based on algorithmic predictions [13] , there are no published reports on the antigenicity, immunogenicity and precise localization of these determinants. Keeping in view the importance of subunit vaccine, the aim of the present study was to delineate the major and minor antigenic sites on F1 antigen. Antibodies against peptides as well as cognate protein have been generated in a murine system using liposomal delivery. The inhibition of antibody binding to F1 antigen was studied through competition assays using di¡erent peptides synthesized from the C-terminal region of F1 antigen. This was further authenticated by studying the immunoreactivity between anti-F1 sera with peptides as well as between peptide sera with cognate antigen. The study highlights the identi¢cation of immunodominant peptide FFVRSIGSKGGKLAAG-KYTDAVTV (142^165) as the major, while the rest of the sequences seem to be minor determinants.
Materials and methods

Selection and synthesis of peptides
Five peptide sequences spanning the C-terminal regions of F1 protein were predicted according to hydrophilicity, exponential surface accessibility, £exibility, antigenicity and amphipathicity scales [14^16] using the Protean program of DNAstar software package. These are represented as :
All the selected sequences were synthesized by the solid phase technique using t-Boc chemistry assembled on modi¢ed Pam resin [17] . After usual cleavage and puri¢cation, all the peptides were authenticated by physico-chemical methods and further purity was checked by high performance liquid chromatography and amino acid analysis.
Liposomes preparation
Liposomes were prepared according to our reported protocol [18] . Brie£y, phosphatidyl choline, cholesterol and phosphatidyl glycerol in the molar ratio of 7:4:1 were rotary evaporated in 15 ml of chloroform:methanol (2:1). The lipid ¢lm obtained was dried by vacuum desiccation overnight and then rehydrated with normal saline. Multilamellar vesicles thus obtained were probe-sonicated to small unilamellar vesicles (SUVs) followed by addition of F1 antigen (2 mg) or peptide (5 mg) to the SUVs and freeze-dried. After rehydration and suspending in 5 ml phosphate-bu¡ered saline (PBS) (0.1 M, pH 7.25), liposomes were ultracentrifuged at 100 000Ug for 1 h at 4³C. The liposome pellet thus obtained was then resuspended in normal saline (1 ml) and stored at 320³C until use. A known amount of the liposome was lysed using 1% Triton X-100 in PBS and released peptide content was estimated by Bradford's method [19] and the e¤ciency of the F1 antigen/peptide entrapped in liposomes was found to be in the range of 40^45%. (F1 antigen was kindly provided by Dr. A. Friedlander, USAMRIID, Fort Detrick, MD, USA).
F1 polymer preparation
F1 polymer was prepared using the glutaraldehyde method. Brie£y, 300 Wg of F1 antigen was dissolved in 1 ml PBS (0.05 M, pH 6.8) and 8 Wl of glutaraldehyde (25%) was added at a ¢nal concentration of 0.25% and kept on an end to end shaker for 1 h. At the end of the coupling, the reaction product was treated with sodium cyanoborohydride (1%, 50 Wl). The reaction product was ¢nally dialyzed against PBS (0.1 M, pH 7.25) at 4³C for 24 h and stored at 320³C until further use.
Mice
Six^eight-week-old inbred mice BALB/c (H-2 d ), C57BL/ 6J (H-2 b ), FVB/J (H-2 q ) and CBA/J (H-2 k ) were obtained from the breeding facilities of National Institute of Immunology, New Delhi, India. F1 polymer antisera were raised in outbred mice of similar age group. Each experimental group consisted of six animals.
Antigen formulations
Mice were immunized with the following optimal dose of antigen.
1. Five Wg of F1 antigen in liposomes (monomeric form). 2. Five Wg of F1 polymer in liposomes (multimeric form). 3. Twenty-¢ve Wg of P1, P2, P3, P4 and P5 peptides in liposomes. These formulations were adsorbed on alum (Superfos Biosector, Denmark) before immunization.
Animal immunization
Mice were immunized subcutaneously on footpad with the above formulations on day zero. Booster immunizations were given on days 21 and 35 with half the primary dose. Mice were bled from the retro-orbital plexus on days 28, 42 and 60 (the third bleed was collected without booster). Sera were separated and stored at 320³C until use. Pooled mice sera of each group of the second bleed (42 day) were used in all the described experiments.
Capture antigen for enzyme-linked immunosorbent assay (ELISA)
Peptide-bovine serum albumin (BSA) conjugate was used as capture antigen for ELISA. Conjugation was done using the glutaraldehyde method. Brie£y, peptide and BSA were taken in 1:3 ratio (100 Wg:300 Wg) with 8 Wl of glutaraldehyde in 1 ml PBS (0.05 M, pH 6.8) and kept on end to end shaker for 1 h, Schi¡'s base linkage was reduced, aliquoted and stored at 320³C until use.
Competitive ELISA
The speci¢cities of antibodies raised against native antigen and peptides in di¡erent strains of mice and rabbit were evaluated by a competitive assay. (Rabbit antiserum was kindly provided by Dr. Almeida, Centro de Pesquisas Aggeu Magalhaes, Recife, PE, Brazil). Brie£y, varying amounts (1^50 Wg) of peptides P1, P2, P3, P4 and P5 were incubated with appropriate dilution of F1 antisera (H-2 q , 1:25 600; H-2 b , 1:25 600; H-2 d , 1:6400 ; H-2 k , 1:12 800 and rabbit 1:1000 that gave an absorbance of 1.0) for 2 h at 37³C. The above complex was then transferred onto the wells of EIA plates (Immulon II, Dynatech, VA, USA) previously coated with F1 antigen (100 ng well 31 ) and blocked (5% skimmed milk powder in PBS (0.1 M, pH 7.25) and incubated at 37³C for 1 h). After three washes with PBS-Tween (0.05%), goat anti-mouse/ anti-rabbit IgG HRPO conjugate (1:1000) was added and incubated for 1 h at 37³C. The color was then developed and absorbance was read at 492 nm. Parallel experiments were done by incubating increasing amounts of F1 antigen (0.125^20 ng) with F1 antisera under identical assay conditions. The results were expressed as the percentage of the antibody binding detected in wells without competitor seen in the wells with a given peptide. The same experimental assay procedure was adopted with F1 polymer antisera with all the peptides as competitor at an antisera dilution 1:8000.
Similar competition assays were performed using antisera raised against ¢ve peptides and then incubated with varying amounts of F1 antigen (1^4 Wg). The complex was then transferred onto the EIA plates previously coated with respective peptide-BSA conjugate (100 ng well 31 ). All subsequent steps carried out were the same as described above.
Direct binding assay
Reactivity of F1 antisera with di¡erent peptides was studied by direct binding assay. The plates were coated with peptide-BSA conjugate (100ng well 31 ). After usual blocking and washes, anti-F1 sera raised in di¡erent inbred strains of mice, rabbit and anti-F1 polymer sera was added in serial 2-fold dilution (1:100^51 200) onto the wells of EIA plates and color was developed as described above. A converse experiment was also performed. Brie£y, plates coated with F1 antigen (100 ng well 31 ) were incubated with serial 2-fold dilution of peptide antisera (1:100^51 200) and the titers were estimated. Titers were assessed as the highest sera dilution giving an absorbance as that of pre-immune sera (v 0.2). All the experiments were done twice and in duplicate wells. 
Results
Competition assay of F1 antisera with di¡erent peptides
The pattern of binding of di¡erent peptides with F1 antisera raised in di¡erent inbred strains of mice is shown in Fig. 1 . Among the individual peptides competed with anti-F1 sera (mice/rabbit), only P2 peptide showed competition in a dose dependent manner. None of the other peptides showed binding even at high a concentration of competitor used. However, there was strain to strain variation in ¢xing the antisera dilution as well as the competition observed with P2 peptide. Ten Wg of P2 peptide showed 50% binding in mice bearing the haplotype H-2 q strain while 40 Wg was required for the other three strains to achieve the same percentage of binding.
Antibody quality in this study has been measured by three criteria : (i) the dilution of antiserum giving an absorbance equivalent to pre-immune sera, (ii) the dilution of antisera giving an absorbance of 1.0, (iii) the amount of peptide required to compete with 50% of binding at the dilution of the antiserum giving an absorbance of 1.0. Based on the ¢rst criterium, all four mice strains produced an equivalent antibody response. However, based on all the criteria, the best response was produced by mice bearing the haplotype H-2 q (Fig. 1 , Table 1 ). There was a 4-fold di¡erence for binding to P2 peptide between mice bearing the haplotype H-2 q and other strains. This suggests that the antisera raised in H-2 q seem to have generated relatively high a¤nity antibodies as compared to other haplotypes. When the same experiment was repeated with rabbit antisera, in this case, competition was also observed only with P2 peptide and 50% inhibition in binding was obtained at 1 Wg of this peptide (Fig. 2) . In case of F1 polymer antisera which were raised in outbred mice, the amount of competitor (P2 peptide) required to achieve 50% inhibition of binding of antibody to native antigen was found to be 30 Wg (Fig. 3) .
When F1 antigen was used as a competitor with its own antisera, the same pattern of binding was observed in all the strains. The amount of antigen required for 50% binding ranged between 2.5 and 5 ng for di¡erent inbred and outbred strains of mice. In case of rabbit sera, the amount of antigen required was very low (0.6 ng) ( Table 1) .
Competition assay of peptide antisera with F1 antigen
As a further test of speci¢city, we performed another set of competitive ELISAs where we veri¢ed the competition between F1 antigen and peptide for peptide speci¢c antisera. It was interesting to note that amongst all the peptide antisera incubated with native F1 antigen, only the binding of P2 antisera with its own peptide was inhibited signi¢cantly. Fifty percent binding of P2 antisera was achieved at 2 Wg of the F1 antigen (Table 2 ). However, for other peptide antisera, there was no competition between F1 antigen and peptides for binding, recon¢rming immunodominance of P2 peptide as compared to other peptide sequences.
Direct binding assay of F1 antisera with di¡erent peptides
In the next set of experiments, reactivity of antisera raised against F1 antigen in mice and rabbit to di¡erent peptides was tested by direct binding assay. The solid phase assay was capable of di¡erentiating between the reactivity of F1 antisera with di¡erent peptides, as seen by the di¡erence in antibody titers. The maximal immunoreactivity was observed with P2 peptide for all strains of mice and rabbit (Table 3) . However, the titers at which anti-F1 antisera reacted with the other four peptides were at very low dilution (1:800^1 :3200) for sera raised in different strains of mice as well as in rabbit. The reactivity of P2 peptide with anti-F1 polymer sera in terms of speci¢ed titers is less when compared to intact monomeric F1 sera but higher than rabbit sera. The results were in conformity that P2 peptide was the dominant epitope on F1 antigen and also the sequence appears to be highly immunogenic.
Direct binding assay of peptide antisera with F1 antigen
We then tested the reactivity of di¡erent peptide antisera with F1 antigen in solid phase assay. The results clearly indicate that for all the peptide sera though able to recognize the native F1 antigen, there was a variation among di¡erent sequences in terms of achieving maximum antibody titers (Table 4 ). In contrast to the above results, the maximum antibody titers were observed for P4 antisera as compared to other peptides.
Discussion
Synthetic peptides containing tailor made sequences derived from the native proteins have introduced a new dimension in understanding antigen-antibody interactions, generating epitope-based vaccines as well as immunodiagnostics. Vaccines derived from peptides have the advantage of providing potential immunogenicity without the side e¡ects as compared to intact pathogen [20] , but the usefulness of such sequences as vaccine immunogens depends on identifying the protective B-and T-cell determinants Though this approach has showed optimism for most of the infectious diseases, its applicability still awaits attention.
As there are limitations on the number of peptide(s) which could be synthesized and tested in animal models for their biological as well as immunological parameters, the selection of peptide(s) is often made on the basis of predictive algorithmic studies [15, 16, 21] . Therefore, in the present study, an attempt was made to map the major and minor antigenic sites of F1 antigen of Y. pestis.
The observation on F1 antibodies undoubtedly con¢rms that F1 is highly immunogenic based on antibody titers as well as the immune response observed in di¡erent strains. Though the peptides are normally poor immunogens, a liposomal approach invariably generated a reasonably high titer antibody response in all the strains (manuscript in preparation).
The results of competitive ELISA of ¢ve peptides with F1 antisera raised in di¡erent strains show that only one of the peptides, i.e. P2 peptide, competes with F1 antigen for its binding to F1 antisera. However, higher amounts of the peptide were required to achieve comparable binding (50%) to that of the native protein. A plausible explanation as to why the other four peptides were unable to compete with native antigen could be that their binding to the F1 antibody appears to be weak. Since the assay was done in solution phase, structural features of the free peptides were maintained during the competition assay with solution phase antigen, thereby avoiding any possible conformational changes caused by binding of antigen to the plastic surfaces. The recognition of P2 peptide by F1 antisera shows that the linear peptide sequence mimics the native structure or portion of the whole protein. The results indicate that P2 peptide is one of the immunodominant sequences and a highly immunogenic sequence of F1 protein, which is recognized by a high proportion of antibodies raised against the native F1 antigen. Also, it can be inferred that this P2 sequence could be present on the surface of the F1 molecule and hence accessible to anti-F1 antibodies.
The above conclusion was further con¢rmed when antisera raised against native antigen reacted with P2 peptide in a conventional solid phase ELISA. However, in this case, the F1 antisera showed immunoreactivity with other peptides, but to a lesser extent. The latter reactivity may represent only a small fraction or population of antibodies elicited by native F1 antigen in immunized host. This contention is supported by the observation that at high dilutions of F1 antisera, only P2 peptide reacted as compared to other peptides. There are several reports in which antibodies raised against native antigen have been found to recognize the denatured protein or fragments of the same protein [22, 23] .
Competitive ELISA of peptide antisera with F1 antigen further strengthens our observations. Only P2 peptide antiserum showed binding to F1 antigen. Recognition of F1 antigen by B-2 peptide antisera in solution phase suggests that these antibodies are produced against a conformationally adopted sequence that is present on the native molecule.
However, the results of other way direct binding assay in which peptide antisera reactivity was tested with native F1 molecule showed very interesting results. All the peptide antisera showed reactivity with cognate protein but the maximum reactivity in this case was observed with P4 antisera. The observed reactivity of all the peptide antisera with F1 antigen may be due to the fact that adsorption of protein to plastic surfaces alters the antigenic structure of protein. It appears that some regular structure of the native conformations is retained while new conformational features are created through partial unfolding of the molecule during its immobilization onto the solid surface. Several investigators have discussed alterations of protein conformations through adsorption to a polymeric surface [20,23^26] .
There are reports indicating that F1 proteins can form polymers that are several MDa in size [27, 28] . Though recombinant or multimeric F1 proteins have shown equal immunogenicity, but their protective e¤cacy with the live bacteria in vivo system has con¢rmed that multimeric F1 antigen is a better candidate immunogen. This study has hypothesized the presence of another region responsible for protective immune response [29] apart from the earlier predicted hydrophilic B-cell epitope TSQDGNNHQ spanning the region (75^83) identi¢ed through molecular modelling [30] .
There are speculations that the C-terminal sequence is involved in polymerization of F1 antigen into a capsular structure with hydrophilic loop TSQDGNNHQ exposed on F1 polymer [30] . Both the competitive as well as direct binding assay showed that the P3 peptide is not accessible on the surface of F1 molecule either in the monomeric or polymeric form. The present study clearly indicates involvement of P2 peptide, which is the part of C-terminal sequence for its recognition with F1 polymer sera. Hence, our study emphasizes that the sequence covering the P2 is not involved in polymerization nor that the hydrophilic loop (P3 peptide) is exposed on the surface of F1 molecule as reported earlier.
Thus, the study highlights the identi¢cation of an immunodominant epitope FFVRSIGSKGGKLAAGKYT-DAVTV (142^165) on F1 molecule that can be exploited for both diagnosis as well as development of subunit vaccine against plague.
